Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3094-09-5

Post Buying Request

3094-09-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3094-09-5 Usage

Description

Doxifluridine is a prodrug derivative of 5-fluorouracil (5-FU). As an antineoplastic it is more potent than 5-FU in the treatment of breast, stomach, colon and rectal cancers.

Chemical Properties

White Solid

Originator

Hoffmann-LaRoche (USA)

Uses

Different sources of media describe the Uses of 3094-09-5 differently. You can refer to the following data:
1. A prodrug of 5-Flurouridine. A fluorinated pyrimidine nucleoside with cytostatic activity
2. An antitumor agent efficient in tumors, cell lines or in fibroblasts tranformed by H-ras or trk oncogenes. A metabolite of Capecitabine
3. 5’-Deoxy-5-fluorouridine is a metabolite of the chemotherapeutic agent Capecitabine (C175650). 5’-Deoxy-5-fluorouridine is an antitumor agent efficient in tumors, cell lines or in fibroblasts tranformed by H-ras or trk oncogenes.
4. antineoplastic, pyrimidine antimetabolite

Definition

ChEBI: A pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluoro racil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase.

Brand name

Furtulon

Biochem/physiol Actions

Doxifluridine is an antitumor agent efficient in tumors, cell lines or in fibroblasts transformed by H-ras or trk oncogenes. Possesses anticachectic activity which is independent of its antiproliferative activity.

Check Digit Verification of cas no

The CAS Registry Mumber 3094-09-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,9 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3094-09:
(6*3)+(5*0)+(4*9)+(3*4)+(2*0)+(1*9)=75
75 % 10 = 5
So 3094-09-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6?,8?/m1/s1

3094-09-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D3579)  5'-Deoxy-5-fluorouridine  >98.0%(HPLC)(T)

  • 3094-09-5

  • 1g

  • 660.00CNY

  • Detail
  • TCI America

  • (D3579)  5'-Deoxy-5-fluorouridine  >98.0%(HPLC)(T)

  • 3094-09-5

  • 5g

  • 1,990.00CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001644)  Capecitabine impurity B  European Pharmacopoeia (EP) Reference Standard

  • 3094-09-5

  • Y0001644

  • 1,880.19CNY

  • Detail
  • USP

  • (1090728)  Capecitabine Related Compound B  United States Pharmacopeia (USP) Reference Standard

  • 3094-09-5

  • 1090728-20MG

  • 14,500.98CNY

  • Detail
  • Sigma

  • (F8791)  5-Fluoro-5′-deoxyuridine  

  • 3094-09-5

  • F8791-25MG

  • 738.27CNY

  • Detail
  • Sigma

  • (F8791)  5-Fluoro-5′-deoxyuridine  

  • 3094-09-5

  • F8791-100MG

  • 2,265.12CNY

  • Detail
  • Sigma

  • (F8791)  5-Fluoro-5′-deoxyuridine  

  • 3094-09-5

  • F8791-250MG

  • 4,960.80CNY

  • Detail

3094-09-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name doxifluridine

1.2 Other means of identification

Product number -
Other names DOXIFLUIRDINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3094-09-5 SDS

3094-09-5Relevant articles and documents

Uracil nucleoside derivative and method for preparing deoxyuridine drug by using same (by machine translation)

-

Paragraph 0068-0072, (2020/05/14)

The invention discloses (I) deoxy - D D-furan ribose 5 - styryl 1 - [2 - (1 - benzoate) derivative represented by the formula] and a preparation method, of the derivative, wherein the structure of the general formula (I) is shown. And the preparation method (I) of, deoxy - D D-furan ribose 5 - styryl 1 - [2 - (1 - benzoate) derivatives as above reaction raw materials can be used as a glycosyl donor to activate] under the conditions of the catalytic amount of the Lewis acid trifluoromethanesulfonate and N - iodosuccinimide, and, reaction efficient, yield 98%. reaching, is avoided in the conventional reaction system using an equivalent or excess of a Lewis acid, benzoyldiimide as a glycosyl donor. (by machine translation)

Synthesis of Nucleosides through Direct Glycosylation of Nucleobases with 5-O-Monoprotected or 5-Modified Ribose: Improved Protocol, Scope, and Mechanism

Downey, A. Michael,Pohl, Radek,Roithová, Jana,Hocek, Michal

supporting information, p. 3910 - 3917 (2017/03/27)

Simplifying access to synthetic nucleosides is of interest due to their widespread use as biochemical or anticancer and antiviral agents. Herein, a direct stereoselective method to access an expansive range of both natural and synthetic nucleosides up to a gram scale, through direct glycosylation of nucleobases with 5-O-tritylribose and other C5-modified ribose derivatives, is discussed in detail. The reaction proceeds through nucleophilic epoxide ring opening of an in situ formed 1,2-anhydrosugar (termed “anhydrose”) under modified Mitsunobu reaction conditions. The scope of the reaction in the synthesis of diverse nucleosides and other 1-substituted riboside derivatives is described. In addition, a mechanistic insight into the formation of this key glycosyl donor intermediate is provided.

A versatile synthesis of 5'-fenctionalized nucleosides through regioselective enzymatic hydrolysis of their peracetylated precursors

Bavaro, Teodora,Rocchietti, Silvia,Ubiali,Filice, Marco,Terreni, Marco,Pregnolato, Massimo

experimental part, p. 1967 - 1975 (2009/09/08)

We describe a chemo-enzymatic synthesis of modified nucleosides through lipase-catalyzed hydrolysis of their peracetylated precursors. It was found from screening of a large number of substrates that these enzymesregioselectivities were affected by the sugar and the nucleobase structures. By selecting the best enzyme for each substrate in terms of activity and regioselectivity, we prepared a small library of differently monodeprotecled purine and pyrimidine nucleosides useful as intermediates for the synthesis of high-value nucleosides and mononucleotides. By this approach, the chemo-enzymatic preparation of doxifluridine (14) and uridine 5'-monophosphate (5'-UMP, 15) from peracetylated uridine 1 was carried out. Elimination of many of the processing stages associated with existing methods was achieved, and higher yields and products of increased purity were generated. Wiley-VCH Verlag GmbH & Co. KGaA.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3094-09-5